Cariprazine

5 trials 4 recruiting NNeurology/Psychiatry

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

1 Completed trials

4 Sponsors

7 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 3

Oversight events:

2 temporary halts across 1 trial

View oversight register →

Indications tested

Schizophrenia 3 Schizoaffective disorder 1 Schizophreniform disorder 1

Sponsors using this IMP

Gedeon Richter Plc. 2 Aalborg University Hospital 1 Medizinische Universitaet Innsbruck 1 Universitair Medisch Centrum Utrecht 1

All trials

5 total

A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to t… Recruiting

2023-506602-39-00 Phase IV 4 countries Universitair Medisch Centrum Utrecht
Safety and Tolerability of Cariprazine in the Treatment of Adolescent Patients with Schizophrenia Recruiting

2024-513222-30-00 Phase III 3 countries Gedeon Richter Plc.
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) Recruiting

2024-517170-20-01 Phase IV 1 country Aalborg University Hospital
An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need … Recruiting

2024-518042-24-00 Phase IV 1 country Medizinische Universitaet Innsbruck
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 years of age) with Schizophrenia Ended

2024-513194-44-00 Phase III 2 countries Gedeon Richter Plc.

Showing 1–5 of 5 trials

← All drugs A–Z